• 1
    Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264265.
  • 2
    Johnson HM, Torres BA. Leukotrienes positive signals for regulation of γ-interferon production. J Immunol 1983; 132: 413416.
  • 3
    Leung KH, Mihich E. Prostaglandin modulation of development of cell-mediated immunity in culture. Nature 1981; 288: 597600.
  • 4
    Kelly JP, Johnson MC, Parker CW. Effect of inhibitors of arachi-donic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. J Immunol 1979; 122: 15631571.
  • 5
    Foegh ML, Khirabadi BS, Rowles JR, Braquet P, Ramwell PW. Prolongation of cardiac allograft survival with BN 52021. A specific antagonist of platelet-activating factor. Transplantation 1986; 42: 8688.
  • 6
    Iyobe T, Izumi R, Shimizu K. Immunosuppressive effect of 5-lipoxygenase inhibitor on liver allotransplantation in rats. Transplantation 1993; 56: 518523.
  • 7
    Jahiel RI, Taylor D, Rainold N, Hirschberg SE, Kroman R. In-ducers of interferon inhibit the mitotic response of liver cells to partial hepatectomy. Proc Nat Acad Sci U S A 1971; 68: 740744.
  • 8
    Hagmann W, Denzlinger C, Keppler D. Role of peptide leuko-trienes and their hepatobiliary elimination in endotoxin shock. Circ Shock 1984; 14: 223235.
  • 9
    Fortner JG, Maclean BJ, Kim DK, Rowland WS, Turnbull AD, Goldiner P, Carlon G. et al. The seventies evolution in liver surgery for cancer. Cancer 1981; 197: 375388.
  • 10
    Thompson HH, Tompkins RK, Longmire WP. Major hepatic resection. A 25-year experience. Ann Surg 1983; 197: 375388.
  • 11
    Higgins GM, Anderson RM. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1981; 12: 186202.
  • 12
    Blair IA, Brash AR, Daugherty J, Fitzgerald GA. Quantitative analysis of leukotriene B4 in human serum. Adv Prostaglandin Thromboxane Leukot Res 1985; 15: 6165.
  • 13
    Hasegawa I, Kawata N, Mizoguchi Y, Kobayashi K, Mizuno M, Morisawa S, Yamamoto Y. Detection of cyclooxygenase and 5-lipoxygenase activity in rat hepatic parenchymal cells [in Japanese]. Acta Hepatol Jpn 1990; 31: 383393.
  • 14
    Trams EG, Symeonidis A. Morphologic and functional changes in the livers of rats after ligation or excision of the common bile duct. Am J Pathol 1957; 33: 1325.
  • 15
    Yoshimoto T, Yokokawa C, Ochi K, Yamamoto S, Maki Y, Ashida Y, Terao S. et al. 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiy-nyl)-1,4-benzoquinone (AA-861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochim Biophys Acta 1982; 713: 470473.
  • 16
    Ashida Y, Saijo T, Kuriki H, Makino H, Terao S, Maki Y. Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor. Prosta-glandins 1983; 26: 955972.
  • 17
    Mathison JC, Ulevitch RJ. The clearance, tissue distribution, and cellular location of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979; 23: 21332143.
  • 18
    Rangel DM, Dinbar A, Stevens GH, Cooper R, Fonkalsrud EW. The hepatic response to endotoxin shock; hemodynamic and enzymatic observations. J Surg Res 1979; 10: 181189.
  • 19
    Bradfield JWB. Control of spillover. The importance of Kupffer-cell function in clinical medicine. Lancet 1974; 12: 883886.
  • 20
    Shirai M, Nishioka M, Shiga J, Mori W, Fukuda I, Kanegasaki S. Fate of 3H-labelled endotoxin in particularly hepatectomized rats. Hepatogastroenterology 1988; 35: 107110.
  • 21
    Matthay MA, Eschenbacher WL, Goetzl EJ. Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome. J Clin Immunol 1984; 4: 479486.
  • 22
    Kimura F, Miyazaki M, Udagawa I, Koshikawa H, Okui K. Experimental study on liver regeneration after partial hepatectomy in obstructive jaundice followed by drainage [in Japanese]. Jpn J Gastroenterol Surg 1990; 23: 18421849.
  • 23
    Aronson KF. Liver function studies during complete extra-hepatic biliary obstruction in the dog. Acta Chir Scand Supp 1961; 275: 1114.
  • 24
    Keppler D, Hagmann W, Rapp S, Denzlinger C, Koch HK. The relation of leukotrienes to liver injury. Hepatology 1985; 5: 883891.
  • 25
    Rola PM, Chavaillaz PA, Lemaire I. Stimulation of interleukin-2 and interferon gamma production by leukotriene B4 in human lymphocyte cultures. Prostaglandins. Leukot Med 1986; 23: 207210.
  • 26
    Mizoguchi Y, Sakagami Y, Seki S, Kobayashi K, Yamamoto S, Morisawa S. Protective effects of a leukotriene inhibitor in an experimental massive hepatic cell necrosis model. Gastroenterol Jpn 1988; 23: 263267.
  • 27
    Kioka K, Mizoguchi Y, Ichikawa Y, Sakagami Y, Kobayashi K, Morisawa S, Yamamoto S. Leukotriene receptors of isolated rat hepatocytes [in Japanese]. Acta Hepatol Jpn 1991; 32: 6366.
  • 28
    Takada T, Hanyu F, Kobayashi S, Uchida Y. Percutaneous trans-hepatic cholangial drainage: direct approach under fluoroscopic control. J Surg Oncol 1976; 8: 8397.
  • 29
    Hatfield ARW, Tobias R, Terblanche J, Girdwood AH, Fataar S, Harries-Jones R, Kernoff L. et al. Preoperative external biliary drainage in obstructive jaundice. Lancet 1982; 23: 896899.
  • 30
    Norlander A, Kalin B, Sundblad R. Effect of percutaneous trans-hepatic drainage upon function and postoperative mortality. Surg Gynecol Obstet 1982; 155: 161166.
  • 31
    McPherson GAD, Benjamin IS, Hodgson MJF. Preoperative percutaneous transhepatic biliary drainage; the results of a controlled trial. Br J Surg 1984; 71: 371375.